Emerson Group hires CVS’ Elizabeth Karvonen
WAYNE, Pa. — Former CVS/pharmacy product development manager Elizabeth Karvonen has joined the Emerson Group, where she will work on the beauty and personal care businesses at CVS/pharmacy.
Prior to joining the Emerson Group, Karvonen was a product development manager at CVS/pharmacy, where she developed private-label beauty and personal care products. In her first year, she developed more than 160 private-label products and was responsible for supply chain and logistics for the private-label beauty and personal care categories.
Express Scripts to provide services for cancer side effect treatment
ST. LOUIS — Pharmacy benefit manager Express Scripts will provide services for patients using a drug to manage a debilitating side effect of many anti-cancer treatments, ESI said.
The PBM announced that it would provide services for Access Pharmaceuticals’ MuGard through its HealthBridge Pharma & Biotech division. MuGard is an oral wound rinse and coating used to manage oral mucositis. ESI said it would be the exclusive provider of third-party logistics, or 3PL services for the product, and the preferred specialty pharmacy for patients using it, through subsidiary CuraScript.
"We are excited about working with Access Pharmaceuticals as a fully integrated supply chain partner," ESI VP strategy and contracting for pharmaceuticals and biotechnology Kevin Cast said. "The award of an exclusive 3PL position and preferred specialty pharmacy position for MuGard is absolute validation of our commitment to providing vital access solutions for pharmaceutical and biotech organizations."
GSK announces strategic partnership with McLaren
LONDON — GlaxoSmithKline and McLaren Group have entered a long-term strategic partnership.
Running initially until 2016, McLaren will help deliver world-class performance across GSK’s global businesses, including its Consumer Healthcare, manufacturing and research and development divisions.
Also part of the agreement, the companies will build a new state-of-the-art learning facility, McLaren GSK Centre for Applied Performance, which will focus on developing U.K. engineering skills and processes. It will be located at McLaren’s headquarters in Woking, England, and open in 2013.
“I am delighted to announce this partnership with McLaren, which brings together two British companies whose continued success hinges on the ability to innovate and rapidly respond to change and competitor activity. McLaren has an unparalleled reputation for innovation built on rigorous analytics and fast decision making,” GSK CEO Andrew Witty said. “This partnership is another example of GSK looking outside its sector for inspiration and fresh perspectives on how we can achieve our strategic goals in an ever more challenging and fast changing business environment.”